Skip navigation
 
Advanced search        
 
NIDDK Home : Special Reports, Planning, Coordination, and Testimony : DRWG News : Diabetes Mellitus: Challenges and Opportunities, Table of Contents : Agenda

Continue to Breakout Groups

Diabetes Mellitus: Challenges and Opportunities
Final Report and Recommendations

Agenda

Thursday, September 4, 1997

7:30 am Registration &
Continental Breakfast
8:30 am WELCOME
Phillip Gorden, M.D.
Director, NIDDK
8:45 am PLENARY SESSION Chairman
Harold Varmus, M.D., Director, NIH
9:00 am OVERVIEW OF TYPE 1 DIABETES MELLITUS
Conference Co-chair:
Arthur H. Rubenstein, M.D.
University of Chicago
9:30 am INSULIN ACTION AND THE PROBLEM OF TYPE 2 DIABETES
Conference Co-chair:
C. Ronald Kahn, M.D.
Harvard Medical School
10:00 am OBESITY AND DIABETES
Jeffrey Friedman, M.D., Ph.D.
Rockefeller University
10:30 am-11:00 am COFFEE BREAK
11:00 am T HELPER CELLS AND AUTOIMMUNITY
Laurie H. Glimcher, M.D.
Harvard Medical School
11:30 am GENETICS OF DIABETES MELLITUS
John A. Todd, Ph.D.
Welcome Trust Center
for Human Genetics
12:00 pm-1:00 pm LUNCH BREAK
1:00 pm-6:00 pm BREAKOUT SESSIONS


Co-CHAIRS AT LARGE
C. Ronald Kahn, M.D.
Arthur H. Rubenstein, M.D.

  • ETIOLOGY AND PATHOPHYSIOLOGY OF TYPE 1 DIABETES MELLITUS
    (Location: Balcony A)

    Co-chairs:
    Daniel W. Foster, M.D.
    University of Texas
    Southwestern Medical Center
    Ake Lernmark, Ph.D.
    University of Washington
  • ETIOLOGY AND PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS
    (Location: Boston Room)

    Co-chairs:
    Jerrold M. Olefsky, M.D.
    University of California
    San Diego
    Kenneth S. Polonsky, M.D.
    University of Chicago
  • THERAPY
    (Location: Balcony B)

    Co-chairs:
    James R. Gavin III, M.D., Ph.D.
    Howard Hughes Medical Institute
    David M. Nathan, M.D.
    Harvard Medical School
  • MACROVASCULAR COMPLICATIONS OF DIABETES MELLITUS
    (Location: Balcony C)

    Co-chairs:
    Antonio M. Gotto, Jr., M.D.
    Cornell University Medical College
    Willa Ann Hsueh, M.D.
    University of Southern California
    Medical Center
  • MICROVASCULAR COMPLICATIONS OF DIABETES MELLITUS
    (Location: Room G1 and G2)

    Co-chairs:
    Michael A. Brownlee, M.D.
    Albert Einstein College of Medicine
    Daniel Porte, Jr., M.D.
    University of Washington
6:00 pm-7:30 pm DINNER
7:30 pm-10:00 pm OPPORTUNITY FOR WORKING GROUPS TO RECONVENE

Friday, September 5, 1997

7:30 am Registration & Continental Breakfast
7:30 am-8:30 am OPPORTUNITY FOR WORKING GROUPS TO RECONVENE
8:30 am-10:10 am PLENARY SESSION
CO-CHAIRS AT LARGE
C. Ronald Kahn, M.D.
Arthur H. Rubenstein, M.D.
REPORTS FROM BREAKOUT SESSIONS
8:30 am ETIOLOGY AND PATHOPHYSIOLOGY OF TYPE 1 DIABETES MELLITUS
Co-chairs:
Daniel W. Foster, M.D.
Ake Lernmark, Ph.D.
8:50 am ETIOLOGY AND PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS
Co-chairs:
Jerrold M. Olefsky, M.D.
Kenneth S. Polonsky, M.D.
9:10 am THERAPY
Co-chairs:
James R. Gavin III, M.D., Ph.D.
David M. Nathan, M.D.
9:30 am MACROVASCULAR COMPLICATIONS OF DIABETES MELLITUS
Co-chairs:
Antonio M. Gotto, Jr., M.D.
Willa Ann Hsueh, M.D.
9:50 am MICROVASCULAR COMPLICATIONS OF DIABETES MELLITUS
Co-chairs:
Michael A. Brownlee, M.D.
Daniel Porte, Jr., M.D.
10:10 am-10:30 am COFFEE BREAK
10:30 am-12 Noon General discussion by all the conference participants.
The recommendations of the groups will be critiqued and
additional suggestions and alternative viewpoints
will be encouraged.
12 Noon-1:00 pm LUNCH BREAK
1:00 pm-3:00 pm Continuation of discussion by all conference participants.
3:00 pm ADJOURNMENT

Continue to Breakout Groups

General inquiries may be addressed to: Office of Communications & Public Liaison
NIDDK, NIH
Building 31. Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
USA